MOBILE VIEW  | 

FLUORINATED HYDROCARBONS

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Most fluorinated hydrocarbons are gases in their natural state. Dibromotetrafluoroethane (Halon 2402) is a liquid.
    B) Fluorinated compounds used as anesthetic drugs are discussed in separate managements (eg, enflurane and isoflurane).
    C) Polymerized fluorocarbons are discussed in the Polymer Fume Fever management.

Specific Substances

    A) Bromochlorodifluoromethane
    1) BCF
    2) Halon 1211
    3) CAS 353-59-3
    Dibromotetrafluoroethane
    1) 1,2-dibromo-1,1,2,2-tetrafluoroethane
    2) Halon 2402
    3) Fluorocarbon 114B2
    4) CAS 124-73-2
    Dichlorodifluoromethane
    1) F-12
    2) CFC12
    3) Freon 12
    4) CAS 75-71-8
    Dichlorofluoroethane
    1) CAS 75-43-4
    Difluoroethane
    1) 1,1-Difluoroethane
    2) CAS 75-37-6
    3) Difluoroetano
    4) Ethylene Fluoride
    5) HFC-152a
    6) Propellant 152a
    Trichlorofluoromethane
    1) Fluorocarbon no. 11
    2) Fluorotrichloromethane
    3) Freon 11
    4) Trichloromonofluoromethane
    5) CAS 75-69-4
    Trichlorotrifluoroethane
    1) Freon 13
    2) TCTFE
    3) CAS 76-13-1
    Bromotrifluoromethane
    1) Halon 1301
    2) CAS 75-63-8
    Additional Compounds
    1) PROPELLANT 22 (CHLORODIFLUOROMETHANE)
    2) CHLORTRIFLUORAETHYLEN
    3) CMB
    4) ETHYLIDINE FLUORIDE
    5) F14 (CARBON TETRAFLUORIDE)
    6) F22 (CHLORODIFLUOROMETHANE)
    7) FC-15
    8) FC14 (CARBON TETRAFLUORIDE)
    9) FLUOROCARBON 1011
    10) CFC22
    11) METHYL CHLOROBROMIDE
    12) TRIFLUOROMETHYLCHLORIDE
    13) PROPELLANT C 318
    14) R14 (CARBON TETRAFLUORIDE)
    15) R22 (CHLORODIFLUOROMETHANE)
    16) REFRIGERANT 22 (CHLORODIFLUOROMETHANE)
    17) TETRACHLORODIFLUOROETHANE
    18) TETRAFLUOROMETHANE, COMPRESSED
    19) TRIFLUORCHLORETHYLEN
    20) TRIFLUOROCHLORETHYLEN (CZECH)
    21) TRIFLUOROCHLOROETHYLENE, INHIBITED
    22) FLUOROCARBON 22 (CHLORODIFLUOROMETHANE)

Available Forms Sources

    A) SOURCES
    1) Automatic fire suppression system (FSS) contains hydrofluorocarbon, a chemical extinguishing agent, which releases hydrogen fluoride at high temperatures. Three soldiers presented with dyspnea that progressed to respiratory failure after an automatic fire suppression system in their military vehicle was damaged by a rocket-propelled grenade, releasing hydrogen fluoride gas. Despite supportive care, all 3 patients died within 24 hours of exposure (Zierold & Chauviere, 2012). Refer to "HYDROFLUORIC ACID" document for exposure to hydrogen fluoride gas.
    2) Halon 2402 is a liquid at normal temperature and pressure. It is available in a consumer product (Fire Knock-Out(R)), a fire-suppressant Christmas tree ornament. The maximum expected air concentrations from breakage of one ornament is around 300 ppm, according to the manufacturer.
    B) USES
    1) The fluorinated hydrocarbons are used as refrigerants, industrial solvents, fire extinguishers, local anesthetics, glass chillers, but mainly as a propellant in most of the 2 million types of aerosols in this country. There are 9 fluorinated hydrocarbons, but the most common are Freon 11, 12 and 114. They are gas normally, a liquid under pressure and non-flammable. Other common names are Genetron, Halon, Isotron, and Ucon. The first synthesized and most commonly used fluorinated hydrocarbon is dichlorodifluoromethane or Freon 12.
    2) Difluoroethane is a newer propellant and refrigerant found in a variety of commercial products including aerosols. It is found in some commercial computer keyboard cleaners. At least one death has been associated with its improper use (Xiong et al, 2004).
    a) In a study of volatile substance misuse in Washington state from 2003 to 2012, 56 deaths were reported. Difluoroethane was listed as the substance in 30 (54%) of 56 deaths. The products used included dust cleaner products (ie, Dust-Off, gas duster, dust destroyer, computer keyboard cleaner, canned air, or compressed air). Although many substances are involved in volatile substance misuse, it was noted that deaths associated with diflouorethane increased during the study period (Ossiander, 2015).
    3) The uses of these compounds has been reduced because of effects on the ozone layer of the atmosphere. However, their presence is not expected to lessen for several years.

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: Fluorinated hydrocarbons are utilized in refrigerants, industrial solvents, fire extinguishers, anesthetics, glass chillers, and propellants. They are also found in commercial keyboard cleaners. Deliberate inhalational abuse of these agents also occurs, primarily by adolescents.
    B) TOXICOLOGY: Fluorinated hydrocarbons toxicity can affect various organ systems. The high degree of lipophilicity can cause euphoria and CNS depression. Displacement of oxygen from air causes hypoxemia. Myocardial sensitizers increase the risk of cardiac dysrhythmias by multiple mechanisms, including alteration of the potassium current, prolonged repolarization, and catecholamine surge, which initiate the dysrhythmias. Also, alteration in calcium release from the sarcoplasmic reticulum depresses atrial conduction and prolongs atrial refractory periods, leading to a prolongation in AV nodal conduction time. Direct tissue injury may also result, causing cardiomyopathy. Frostbite can also occur as a result from direct skin freezing. Irritation can occur, secondary to production of irritant acids, such as hydrochloric acid, after the chemical is heated. Hepatotoxicity can also occur after acute or chronic exposure. Renal injury, secondary to byproduct degradation, can cause albuminuria and glucosuria.
    C) EPIDEMIOLOGY: Exposure is common. Serious toxicity is rare and almost always from deliberate abuse or occupational exposure in a confined space. At high temperatures, these chemicals can decompose to hydrogen fluoride, and exposure, particularly in confined spaces, can cause severe toxicity (refer to hydrofluoric acid management).
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: Patients may complain of mucous membrane/ocular irritation, defatting injury of the skin, and frostbite after exposure to cold gas. High pressure digit injury can also occur, resulting in digital ischemia. Systemic effects include headache, nausea, vomiting.
    2) SEVERE TOXICITY: Can cause depressed mental status, respiratory depression, pulmonary edema, malignant ventricular dysrhythmias, and sudden death. Hepatic and renal injury can also occur.
    0.2.20) REPRODUCTIVE
    A) Dichlorodifluoromethane was not teratogenic in rats and rabbits.
    B) The reproductive effects of 1,1,1,2-tetrafluoroethane were studied in rats. No adverse effects on reproductive performance was noted or on the development, maturation or reproductive performance of up to two successive generations.

Laboratory Monitoring

    A) Monitor liver enzymes, serum electrolytes and renal function in symptomatic patients.
    B) Most patients with minor exposure need no specific studies.
    C) Obtain a chest radiograph in any patient with pulmonary symptoms.
    D) Monitor pulse oximetry, institute continuous cardiac monitoring and obtain an ECG.
    E) Expired air levels can be obtained, but these are not available or clinically relevant in the emergency setting.

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Treatment is primarily supportive with removal from source, appropriate decontamination and oxygen administration.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Remove patient from exposure, decontaminate, and administer oxygen. Aggressive airway management for patients with respiratory or mental status depression should be instated along with supportive measures for hypotension. Administer nebulized bronchodilators (eg, albuterol) for respiratory irritation or bronchospasm. Consider surfactant administration (80ml/m(2) divided into 4 aliquots given every 12 hours through the endotracheal tube using four positions-left decubitus, head-up then down, right decubitus, head-up then down) for patients with a severe pneumonitis requiring intubation. Treat tachydysrhythmias with esmolol 0.025 to 0.1mg/kg/min IV. Cardiovert unstable ventricular dysrhythmias. Consider early ECMO for pediatric patients with severe pneumonitis. Consider N-acetylcysteine for severe liver injury.
    C) DECONTAMINATION
    1) PREHOSPITAL: Prehospital GI decontamination is not recommended.
    2) HOSPITAL: There are very few reports of ingestion of these products, but one resulted in gastric perforation. GI decontamination is generally not indicated.
    D) AIRWAY MANAGEMENT
    1) Patients with CNS or respiratory depression or hemodynamic instability should be intubated.
    E) ANTIDOTE
    1) There is no antidote for fluorinated hydrocarbons.
    F) ENHANCED ELIMINATION PROCEDURE
    1) There is no evidence to support hemodialysis, hemoperfusion, diuresis or multi-dose activated charcoal.
    G) PATIENT DISPOSITION
    1) HOME CRITERIA: Instate home management only if patient is asymptomatic, exposure was minimal and there is no suspicion for self-harm.
    2) OBSERVATION CRITERIA: Observe all patients until completely asymptomatic.
    3) ADMISSION CRITERIA: Admit any patient with altered mental status, hemodynamic instability, history of an intentional ingestion, suspected or known significant overdose or high pressure digit injury.
    4) CONSULT CRITERIA: Involve a toxicologist or poison center immediately if there is concern for intentional or significant overdose. Consult an orthopedic surgeon if there is concern for a high pressure digit injury. Consult ophthalmology if corneal injury is suspected and involve a burn surgeon as needed.
    H) PITFALLS
    1) Appropriate therapy may be delayed due to failure to refer to a material safety data sheet for chemical information and failing to recognize a high pressure digit injury. Beware of secondary exposures that may come from rescuers who were also exposed to compounds within an enclosed setting.
    I) TOXICOKINETICS
    1) These agents are rapidly absorbed by the lungs, with a nearly immediate onset of action. Primary elimination is via exhaled breath.
    J) DIFFERENTIAL DIAGNOSIS
    1) It is important to also consider symptoms of toxicity may be due to volatile hydrocarbons (gasoline and toluene), alkyl nitrites (amyl nitrite), and/or nitrous oxide.
    0.4.3) INHALATION EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Treatment is primarily supportive with removal from source, appropriate decontamination and oxygen administration.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Remove patient from exposure, decontaminate, and administer oxygen. Aggressive airway management for patients with respiratory or mental status depression should be instated along with supportive measures for hypotension. Administer nebulized bronchodilators (eg, albuterol) for respiratory irritation or bronchospasm. Consider surfactant administration (80ml/m(2) divided into 4 aliquots given every 12 hours through the endotracheal tube using four positions-left decubitus, head-up then down, right decubitus, head-up then down) for patients with a severe pneumonitis requiring intubation. Treat tachydysrhythmias with esmolol 0.025 to 0.1mg/kg/min IV. Cardiovert unstable ventricular dysrhythmias. Consider early ECMO for pediatric patients with severe pneumonitis. Consider N-acetylcysteine for severe liver injury.
    C) AIRWAY MANAGEMENT
    1) Patients with CNS or respiratory depression or hemodynamic instability should be intubated.
    D) ACUTE LUNG INJURY
    1) Supplemental oxygen; PEEP and mechanical ventilation may be needed.
    0.4.4) EYE EXPOSURE
    A) DECONTAMINATION: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, the patient should be seen in a healthcare facility.
    B) Perform a slit lamp exam.
    C) Ophthalmologic consultation should be considered in symptomatic patients.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) DECONTAMINATION: Remove contaminated clothing and jewelry and place them in plastic bags. Wash exposed areas with soap and water for 10 to 15 minutes with gentle sponging to avoid skin breakdown. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    2) If frostbite has occurred, refer to dermal treatment in the main body of this document for rewarming.
    3) If a high pressure injury is suspected, consult an orthopedic surgeon.
    4) Consult a burn surgeon as needed.

Range Of Toxicity

    A) Freons are very toxic when inhaled in high concentrations and/or for extended periods. At lower concentrations or brief exposure, freons may cause transient eye, nose, and throat irritation.
    B) DICHLORODIFLUOROMETHANE: OSHA PEL and NIOSH REL: TWA 1000 parts per million (ppm); 15,000 ppm is considered immediately dangerous to life and health. TRIFLUOROBROMOMETHANE: OSHA PEL and NIOSH REL: TWA 1000 ppm; 40,000 ppm is considered immediately dangerous to life and health. DICHLOROMONOFLUOROMETHANE: OSHA PEL: TWA 1000 ppm, NIOSH REL: TWA 10 ppm; 5,000 ppm is considered immediately dangerous to life and health.

Summary Of Exposure

    A) USES: Fluorinated hydrocarbons are utilized in refrigerants, industrial solvents, fire extinguishers, anesthetics, glass chillers, and propellants. They are also found in commercial keyboard cleaners. Deliberate inhalational abuse of these agents also occurs, primarily by adolescents.
    B) TOXICOLOGY: Fluorinated hydrocarbons toxicity can affect various organ systems. The high degree of lipophilicity can cause euphoria and CNS depression. Displacement of oxygen from air causes hypoxemia. Myocardial sensitizers increase the risk of cardiac dysrhythmias by multiple mechanisms, including alteration of the potassium current, prolonged repolarization, and catecholamine surge, which initiate the dysrhythmias. Also, alteration in calcium release from the sarcoplasmic reticulum depresses atrial conduction and prolongs atrial refractory periods, leading to a prolongation in AV nodal conduction time. Direct tissue injury may also result, causing cardiomyopathy. Frostbite can also occur as a result from direct skin freezing. Irritation can occur, secondary to production of irritant acids, such as hydrochloric acid, after the chemical is heated. Hepatotoxicity can also occur after acute or chronic exposure. Renal injury, secondary to byproduct degradation, can cause albuminuria and glucosuria.
    C) EPIDEMIOLOGY: Exposure is common. Serious toxicity is rare and almost always from deliberate abuse or occupational exposure in a confined space. At high temperatures, these chemicals can decompose to hydrogen fluoride, and exposure, particularly in confined spaces, can cause severe toxicity (refer to hydrofluoric acid management).
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: Patients may complain of mucous membrane/ocular irritation, defatting injury of the skin, and frostbite after exposure to cold gas. High pressure digit injury can also occur, resulting in digital ischemia. Systemic effects include headache, nausea, vomiting.
    2) SEVERE TOXICITY: Can cause depressed mental status, respiratory depression, pulmonary edema, malignant ventricular dysrhythmias, and sudden death. Hepatic and renal injury can also occur.

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) IRRITATION: Eye irritation and burning occur with ambient exposure (Holness & House, 1992).
    a) Transient mild inflammation and conjunctivitis have resulted from application of liquid Freon 11 to rabbit eyes (Grant & Schuman, 1993; Anon, 1968) .
    b) Liquid Halon 2402 was not an eye irritant when instilled into the conjunctival sac of rabbits (Technical Information, 1987b).
    c) 1,1-dichloro-1-fluoroethane is a mild eye irritant in rabbits (Brock et al, 1995).
    2) CORNEAL INJURY: No significant injuries have been reported in the literature from accidental ocular exposure from pressurized containers or refrigerator liquids (Grant, 1986), presumably due to rapid reflex closure of the eyes.
    a) CORNEAL EDEMA was described in 2 patients undergoing cataract extraction following application of liquid Freon-12 to freeze extruding vitreous (Miller & Perdriel, 1964).
    b) ANIMAL EXPOSURE: Deliberate exposure to liquid Freon-12 from a refrigerator to forcibly open rabbit eyes produced effects related to the duration of exposure as follows (Grant & Schuman, 1993):
    1) 1 to 2 seconds: momentary freezing; slight epithelial edema and epithelial loss; recovery in 3 days
    2) 5 to 10 seconds: damage of corneal epithelium, stroma swelling; gradual recovery over 6 weeks
    3) 30 seconds: severe corneal damage with opacity
    3) LID INJURY: Frostbite of the lids may be extensive, requiring debridement and grafting (Kurbat & Pollack, 1998).
    4) After a freezer exploded at a seafood factory, 43 of 80 workers exposed to Freon-22 developed symptoms. The following ocular effects occurred: visual disturbance (n=6), irritation (n=2), lacrimation (n=1), and keratitis (n=2). Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes (Kubota & Miyata, 2005).
    3.4.4) EARS
    A) WITH POISONING/EXPOSURE
    1) TINNITUS: Tinnitus, along with other neurological disorders, occurred in 1 of 80 workers exposed to Freon-22 after a freezer exploded at a seafood factory. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes, and 43 of 80 exposed workers developed symptoms (Kubota & Miyata, 2005).
    3.4.5) NOSE
    A) WITH POISONING/EXPOSURE
    1) IRRITATION: Nasal irritation occurs with ambient exposure (Holness & House, 1992).
    3.4.6) THROAT
    A) WITH POISONING/EXPOSURE
    1) FROSTBITE: Injuries may occur following inhalation exposures.
    a) CASE REPORT: Frostbite of the lips, tongue, buccal mucosa, and hard palate developed in a man after deliberate inhalation of a propellant containing propane and dichlorodifluoromethane (Elliot, 1991).
    b) CASE REPORT: A 16-year-old boy developed frostbite of the lips and tongue, and first-degree burns of the esophagus after deliberate inhalation of an airbrush propellant containing 1,1-difluoroethane (Kuspis & Krenzelok, 1999).
    c) DYSESTHESIA OF THE TONGUE: Dysesthesia of the tongue occurred in 15 of 80 workers exposed to Freon-22 after a freezer exploded at a seafood factory. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes, and 43 of 80 exposed workers developed symptoms (Kubota & Miyata, 2005).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) VENTRICULAR ARRHYTHMIA
    1) WITH POISONING/EXPOSURE
    a) HIGH CONCENTRATIONS: Ventricular fibrillation and ventricular tachycardia have been reported with inhalation exposures to high concentrations, usually deliberate abuse or industrial use or spills in poorly ventilated areas (Brady et al, 1994; Fitzgerald et al, 1993; Lerman et al, 1991; McGee et al, 1990; Clark et al, 1985; May & Blotzer, 1984; Steadman et al, 1984) .
    b) LOW CONCENTRATIONS: No clear connection with exposure and cardiac dysrhythmias was found in 6 refrigerator repairmen (Antti-Poika et al, 1990). Ambulatory electrocardiograms were performed for 24 hours on the day of exposure and on a control day. Peak concentration and average level of exposure reported in the breathing zone were 3200 cm(3)/m(3) and 170 cm(3)/m(3), respectively.
    1) A control group of 6 plumbers were also monitored by ambulatory EKG for 24 hours. One subject in the exposed group had an arrhythmic tendency (frequent unifocal ventricular ectopic beats that often occurred as bigeminy or trigeminy) susceptible to different arrhythmogenic agents such as fluorocarbons and alcohol. Medical examination prior to inclusion attempted to rule out preexisting cardiovascular disease (Antti-Poika et al, 1990).
    2) In a study of 89 refrigerator repairmen exposed to FC 12 and FC 22, no difference in dysrhythmia frequency was found between exposed and unexposed periods (Edling et al, 1990).
    3) In a study of 16 aerospace workers exposed to fluorocarbon 113, no difference in dysrhythmia frequency was found on exposed and unexposed workdays (Egeland et al, 1992).
    4) In a double blind, placebo-controlled study of 10 firefighters exposed to Halon 1211 1000 ppm while exercising, one subject had 49.5 ventricular premature beats/hour during and 8 hours after Halon exposure compared with 8.7 ventricular premature beats/hour during and 8 hours after placebo exposure (Kaufman et al, 1992).
    5) An unintended release of Halon 1301 (CF3Br) in an office with 11 workers resulted in no cardiac signs or symptoms (Call, 1973).
    c) MECHANISM: Fluorinated hydrocarbons are believed to cause dysrhythmias by sensitizing the myocardium to endogenous catecholamines (Voge, 1989). Neuroreflexes from lung receptors may play a role (Aviado & Micozzi, 1981).
    d) Once cardiac dysrhythmias develop, they are difficult to reverse. Ventricular fibrillation that develops following exposure to fluorinated hydrocarbons can be treated by cardioversion; however, not always successfully (Lown, 1977; Lerman et al, 1991).
    B) DEAD - SUDDEN DEATH
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Three men (aged 22 to 41 years) died after inhaling 1,1-difluoroethane (HFC-152a), a common formulation for electronic spray cleaners. No report of intentional suicide was found in all 3 cases. Two spent canisters (approximate volume 500 mL) were found in 1 case, and 1 canister of the same size along with barrier asphyxiants with attached tubes (eg, plastic bag and gas mask) were found with the other 2 cases. All patients were discovered in the early to late stages of rigor mortis. Similar findings on autopsy for each case included cyanosis of the lips and fingernails, alveolar edema, and pulmonary congestion. The man in the first case also had frostbite on the dorsa of the hand, most likely due to extensive exposure to the cold exterior of the canisters while inhaling the fumes(Sakai et al, 2011).
    b) Patients are often described as inhaling fluorinated hydrocarbons, becoming "high," and then developing agitation, being frightened, or engaging in physical exertion (presumably associated with increased endogenous catecholamine levels) followed by sudden collapse (Smeeton, 1985; Kamm, 1975).
    c) CASE REPORT: A 32-year-old man entered a battle tank that had been degreased with trifluorotrichloroethane and rapidly became diaphoretic and lost consciousness. He was pulled from the tank, vomited, and became pulseless and apneic. CPR was initiated. He was asystolic when paramedics arrived and could not be resuscitated (Kaufman et al, 1994).
    C) ATRIAL FIBRILLATION
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Two healthy men became unconscious and developed atrial fibrillation with rapid ventricular response after working in battle tanks that had been degreased with trifluorotrichloroethane (Kaufman et al, 1994). One was treated with digoxin and quinidine and converted to sinus bradycardia with ventricular and atrial ectopy, which resolved over 6 days. The other spontaneously converted to sinus rhythm.
    D) HYPOTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) An anesthetic state induced by 1,1-dichloro-1-fluoroethane has been associated with decreased blood pressure and a nodal cardiac rhythm (Johansson, 1998).
    E) PALPITATIONS
    1) WITH POISONING/EXPOSURE
    a) After a freezer exploded at a seafood factory, 43 of 80 workers exposed to chlorodifluoromethane (Freon-22) developed symptoms. Cardiovascular effects included palpitations (n=3) and chest pain (n=1). Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes (Kubota & Miyata, 2005).
    3.5.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) VENTRICULAR FIBRILLATION
    a) DOGS: In dogs, inhalation of 1,1-dichloro-1-fluoroethane at 20,000 ppm caused myocardial sensitization to intravenous epinephrine (10 micrograms/kilogram), resulting in ventricular fibrillation (Brock et al, 1995).
    b) DOGS: In dogs, dysrhythmias, including fibrillation, were seen on administration of epinephrine, which followed 5 minutes after exposure began; 7.5% was the lowest concentration of fluorocarbon that led to dysrhythmia (Mullin, 1979).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) BRONCHOSPASM
    1) WITH POISONING/EXPOSURE
    a) BRONCHIAL CONSTRICTION: Fluorinated hydrocarbons may cause bronchial constriction when inhaled. Inhalation of a fluorinated hydrocarbon aerosol produced a 20% or greater decrease in FEV1 in asthmatic patients (Sterling & Batten, 1976).
    b) OCCUPATIONAL ASTHMA or RADS: Prolonged hyperreactivity of the airways has been reported in patients working with heated freon, although exposure to combustion products (hydrochloric acid, chlorine, phosgene) may have contributed to this effect (Malo et al, 1984; Field, 1985).
    c) A 10 to 15 minute exposure to a BrF3C (Halon 1301) release without heat has led to a case of RADS with pulmonary hyperreactivity that has persisted for 7 years. The patient had no prior history of allergic or pulmonary disease (de la Hoz, 1999).
    d) Among 39 patients exposed to a mixture of 'fluoroaliphatics' and n-heptane, isobutane, and diethyl acetate, 26 developed cough, 14 chest pain and shortness of breath. Symptoms persisted more than a month in 6 of the patients. Whether this was the fluorocarbon or a combination of 2 or more agents synergistically is not known (Burkhart et al, 1996).
    e) REACTIVE UPPER AIRWAY SYNDROME: A man who developed RADS had symptoms of upper airway hyperreactivity to multiple triggers (de la Hoz, 1999).
    f) CASE SERIES: Reactive airways dysfunction syndrome (RADS) was reported in four patients following exposure to high levels of bromochlorodifluoromethane due to release of contents from a defective fire extinguisher. Two of the 4 patients did not have any medical history of respiratory disease, 1 patient had a history of allergic rhinitis, and 1 patient had a history of childhood asthma, but he had not experienced an asthma attack in the past 10 years. All of the patients experienced cough, dyspnea, asthenia, and dizziness within days following exposure. One patient, who experienced the highest level of bromochlorodifluoromethane exposure, also developed malaise, wheezing, and limb paresthesia (Matrat et al, 2004).
    B) COUGH
    1) WITH POISONING/EXPOSURE
    a) IRRITATION: Fluorinated hydrocarbons may cause lung irritation, cough, and sore throat if inhaled (Holness & House, 1992). Respiratory arrest secondary to presumed asphyxia from displacement of ambient oxygen has been reported following severe inhalational exposure in a confined space (Johansson, 1998).
    C) DYSPNEA
    1) WITH POISONING/EXPOSURE
    a) Dyspnea is an early symptom of severe exposures and is also reported with lower concentration exposures (Holness & House, 1992; Lerman et al, 1991). Chest tightness was reported in 39% of 31 workers exposed to a release of a Halon 1301 fire protection system designed to achieve a 7% concentration (Holness & House, 1992). Other studies found no pulmonary symptoms when the gas was administered at this concentration for 3 minutes (Call, 1973).
    b) Shortness of breath occurred in 5 of 80 workers exposed to Freon-22 after a freezer exploded at a seafood factory. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes, and 43 of 80 exposed workers developed symptoms (Kubota & Miyata, 2005).
    D) ADULT RESPIRATORY DISTRESS SYNDROME
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Adult respiratory distress syndrome was reported in a 60-year-old man after working with heated ski wax in an enclosed area for several hours. Severe respiratory failure developed over the next 24 hours. Endotracheal intubation was required. Severe hypoxemia (PO2=65 mmHg) persisted despite mechanical ventilation. Chest x-ray revealed bilateral reticulonodular infiltrates over both lung areas. The patient recovered over the next 6 days (Bracco & Favre, 1998).
    b) CASE SERIES: Twelve factory workers presented to a local hospital with a dry cough after their shift. Exposure to an open-air discharge of fluorocarbons and pyrolysis products occurred from a neighboring factory approximately 35 meters away. Investigation of the workshop of the exposed factory workers, 22 hours after the discharge, detected perfluoroisobutylene, hydrogen fluoride, hexafluoropropylene, tetrafluoroethylene, and chlorotrifluoroethylene at levels of 0.06, 0.08, 0.7, 1.8, and 0.5 mg/m(3), respectively. One of the 12 patients died of respiratory failure within hours of presentation. The other 11 patients were transferred to another hospital due to increasing dyspnea. Urinalysis revealed a urinary fluoride concentration of greater than 1.72 mcg/mL in all patients, which was at the upper limit of the reference value. Initial chest radiographs in 5 patients demonstrated pulmonary edema, and those 5 patients also met the criteria for acute respiratory distress syndrome (ARDS). Chest radiographs in the other 6 patients showed increased lung markings and mild interstitial infiltrates. Treatment for the ARDS patients included non-invasive positive pressure ventilation (NIPPV) with IV methylprednisolone and inhaled budesonide. Two of the ARDS patients developed subcutaneous emphysema and pneumomediastinum which resolved with NIPPV treatment. CT scan of 4 ARDS patients demonstrated bilateral ground-glass opacities and interstitial pneumonia which gradually improved over a 3-month period. One patient died on day 11 due to ventilator-associated pneumonia (Tan et al, 2016).
    E) ANGIOEDEMA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 40-year-old man presented to the emergency department with numbness and tingling of his lips and tongue 4 hours after deliberate inhalation ("huffing") of a canister containing 1,1-difluoroethane. At presentation, there was significant swelling of the patient's upper and lower lips and oropharynx, with blistering of his oral mucosa and oropharyngeal edema. He was having difficulty breathing and swallowing, necessitating intubation and mechanical ventilation. Following ventilation, the patient presented to the ICU with erythema and significant swelling on the right side of his neck with subsequent development of weeping blisters. A CT of the neck demonstrated extensive soft tissue swelling with evidence of edema on the right side of his upper neck. Laboratory data revealed a WBC of 16,800 cells/mcL with a normal differential and no bands. Improvement in the swelling and blistering occurred following administration of antihistamines, corticosteroids, and bacitracin, and the patient was eventually discharged in stable condition. Interview of the patient revealed that he had been "huffing" 1 canister per day for 3 to 4 years, and had "huffed" 3 canisters on the day of admission (Winston et al, 2015).
    F) ACUTE LUNG INJURY
    1) WITH POISONING/EXPOSURE
    a) CROUP: An 11-year-old developed severe croup, requiring intubation, and pulmonary edema after inhaling a product containing capsaicin and fluorinated hydrocarbons (Winograd, 1977).
    b) Pulmonary edema has been an autopsy finding in fatal cases (Phatak & Walterscheid, 2012; Lerman et al, 1991; McGee et al, 1990; Morita et al, 1977; Kamm, 1975) .
    c) Pulmonary edema was reported in 5 patients with acute respiratory distress syndrome secondary to occupational exposure to fluorocarbons and pyrolysis products, including perfluoroisobutylene, hydrogen fluoride, hexafluoropropylene, tetrafluoroethylene, and chlorotrifluoroethylene (Tan et al, 2016).
    G) BURN OF RESPIRATORY TRACT
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 16-year-old boy developed frostbite of the lips and tongue, first- and second-degree burns of the larynx and vocal cords, and first-degree burns of the trachea and mainstem bronchi after deliberate inhalation of an airbrush propellant containing 1,1-difluoroethane (Kuspis & Krenzelok, 1999).
    H) ALLERGIC PNEUMONIA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 15-year-old boy developed eosinophilic pneumonia and respiratory failure, which responded to steroids after repetitive inhalational abuse of a product containing trichloroethane and fluorocarbons (Kelly & Ruffing, 1993).
    b) ALVEOLITIS has been reported following exposure to a complex mixture containing fluorocarbons. The syndrome was short-lived, responding to steroids (Wright & Lee, 1986).
    I) PHARYNGITIS
    1) WITH POISONING/EXPOSURE
    a) Pharynx irritation occurred in 11 of 80 workers exposed to Freon-22 after a freezer exploded at a seafood factory. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes, and 43 of 80 exposed workers developed symptoms (Kubota & Miyata, 2005).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) HEADACHE
    1) WITH POISONING/EXPOSURE
    a) Headache is a common complaint, reported in 71% of 31 workers exposed to bromotrifluoromethane (Holness & House, 1992).
    b) Headache occurred in 16 of 80 workers exposed to Freon-22 after a freezer exploded at a seafood factory. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes, and 43 of 80 exposed workers developed symptoms (Kubota & Miyata, 2005).
    B) DIZZINESS
    1) WITH POISONING/EXPOSURE
    a) Dizziness was an early symptom noted by soldiers exposed to bromochlorodifluoromethane in a battle tank (Lerman et al, 1991) and following exposure from contents of defective fire extinguishers (Matrat et al, 2004). Lightheadedness was a common complaint (68%) among 31 workers exposed to bromotrifluoromethane (Holness & House, 1992). Dizziness, faintness, and drowsiness were reported at 4% and 7% exposure levels in 3 out of 4 subjects in a controlled exposure (Call, 1973). Prolonged tiredness has occurred (de la Hoz, 1999).
    b) Dizziness occurred in 24 of 80 workers exposed to Freon-22 after a freezer exploded at a seafood factory. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes, and 43 of 80 exposed workers developed symptoms (Kubota & Miyata, 2005).
    C) CLOUDED CONSCIOUSNESS
    1) WITH POISONING/EXPOSURE
    a) Disorientation was a common complaint (29%) among 31 workers exposed to bromotrifluoromethane (Holness & House, 1992).
    D) CEREBRAL EDEMA
    1) WITH POISONING/EXPOSURE
    a) Cerebral edema may be found on autopsy after severe inhalation exposures (Lerman et al, 1991; Kamm, 1975).
    E) PSYCHOTIC DISORDER
    1) WITH POISONING/EXPOSURE
    a) PSYCHOORGANIC SYNDROME: Neuropsychological testing revealed a syndrome of impaired psychomotor speed, impaired learning and memory, and emotional lability in 7 of 21 workers chronically exposed to 1,1,2-trichloro-1,2,2-trifluoroethane (Rasmussen et al, 1988).
    1) Four of these workers had previously been exposed to 1,1,1- trichloroethane, while 3 had no other solvent exposure.
    F) ANXIETY
    1) WITH POISONING/EXPOSURE
    a) A short-term anxiety syndrome has been seen with lowered PCO2 (Gerhardt, 1996).
    G) DISTURBANCE IN THINKING
    1) WITH POISONING/EXPOSURE
    a) NEUROPSYCHIATRIC TEST EFFECTS: Reaction time and maze tracing errors, but not maze tracing time, were diminished to a small but statistically significant extent in 8 airmen exposed to 7% CBrF3 (Call, 1973).
    b) CASE REPORT: A 19-year-old man who presented for psychiatric assessment following probation violation and subsequent incarceration, had a 3-year history of abusing inhalants, primarily with air conditioning fluid. When presenting for psychiatric evaluation, he appeared to be cognitively slower in conversation, although there appeared to be only minimal deficits in short-term memory when tested with the Mini-Mental State Exam (Caplan et al, 2012).
    H) SEIZURE
    1) WITH POISONING/EXPOSURE
    a) Seizures have been observed in experimental animals exposed to Freon-1301 and Freon-21 (Hathaway et al, 1996).
    I) SECONDARY PERIPHERAL NEUROPATHY
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Peripheral neuropathy developed in 2 men anesthetized with 1.25 minimum alveolar concentration of sevoflurane (Goldberg et al, 1999).
    b) After a freezer exploded at a seafood factory, 43 of 80 workers exposed to Freon-22 developed symptoms. Muscle weakness and numbness of legs occurred in 6 and 4 workers, respectively. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes (Kubota & Miyata, 2005).
    J) COMA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 28-year-old woman developed coma after exposure to Freon-22 when a freezer exploded at a seafood factory. Following supportive therapy, she recovered and was discharged 3 days later without any neurological deficits. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes (Kubota & Miyata, 2005).
    K) DISORDER OF BRAIN
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: An 18-year-old man was found dead following deliberate inhalation ("huffing") of difluorochloromethane air conditioner refrigerant. Microscopic examination of the brain during autopsy revealed evidence of cerebral leukoencephalopathy with ischemic or hypoxic neuronal changes. Other findings during the autopsy included pulmonary edema, diffuse visceral congestion, increased intramyocardial fibrosis, and centrilobular hepatic necrosis (Phatak & Walterscheid, 2012).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) NAUSEA
    1) WITH POISONING/EXPOSURE
    a) Nausea developed in 10% of 31 workers exposed to bromotrifluoromethane (Holness & House, 1992).
    b) Nausea occurred in 18 of 80 workers exposed to Freon-22 after a freezer exploded at a seafood factory. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes, and 43 of 80 exposed workers developed symptoms (Kubota & Miyata, 2005).
    B) GASTRIC ULCER
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Tissue necrosis and multiple perforation of the stomach developed in a 43-year-old man after ingesting an unknown amount of a mixture of Freon and water. The postoperative gastric fiberoptic endoscopy revealed 2 notable excavated ulcers with hemorrhagic fundi in the subcardial and back face of the gastric body. Following supportive care, the patient recovered gradually and was discharged on day 10. At a 3 month follow-up, complete healing of the gastric ulcers was observed (Gotelli et al, 2008).
    b) CASE REPORT: Mucosal necrosis and perforation of the stomach developed in one patient after ingesting a small amount of trichlorofluoromethane (Haj et al, 1980).
    c) CASE REPORT: A 16-year-old boy developed frostbite of the lips and tongue, and first-degree burns of the esophagus after deliberate inhalation of an airbrush propellant containing 1,1-difluoroethane (Kuspis & Krenzelok, 1999).

Hepatic

    3.9.2) CLINICAL EFFECTS
    A) LIVER ENZYMES ABNORMAL
    1) WITH POISONING/EXPOSURE
    a) Jaundice and mild elevations of transaminases have been reported rarely after severe inhalation exposure and ingestion (Haj et al, 1980; Steadman et al, 1984).
    b) CASE REPORT: Elevated liver enzymes (2-fold of normal limits) and gastric perforation developed in a 43-year-old man after ingesting an unknown amount of a mixture of Freon and water. Following supportive care, the patient recovered gradually and was discharged on day 10 (Gotelli et al, 2008).
    c) CASE REPORT: After a freezer exploded in a seafood factory, 43 of 80 workers exposed to Freon-22 developed symptoms. Mildly elevated levels of alkaline phosphatase (max range 350-440 International Units/L) and lactic acid dehydrogenase (max range 258-262 International Units/L) were each reported in 3 workers. Levels returned to normal within 7 days. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes (Kubota & Miyata, 2005).
    B) HEPATIC NECROSIS
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: Following repeated accidental exposures in 9 workers to a mixture of 1,1-dichloro-2,2,2-trifluoroethane and 1-chloro-1,2,2,2-tetrafluoroethane, various degrees of liver injuries resulted. Liver biopsy performed in one patient revealed hepatocellular coagulative necrosis. Other workers were diagnosed with hepatitis with elevated hepatic enzyme levels (Hoet et al, 1997).
    b) CASE REPORT: Evidence of centrilobular hepatic necrosis was found during an autopsy of an 18-year-old man found dead following deliberate inhalation ("huffing") of difluorochloromethane air conditioner refrigerant (Phatak & Walterscheid, 2012).

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) INCREASED HEMOGLOBIN
    1) WITH POISONING/EXPOSURE
    a) A community in Taipei, Taiwan, was unintentionally exposed to fire extinguisher gases (mixture of Halon 1301, Halon 1211 and Freon 12), and 117 residents sought medical attention. Laboratory results demonstrated decreased hemoglobin and red blood cell counts. When compared to a nonexposed control group, there were significant differences for hemoglobin and red blood cell counts (p=0.011 and p=0.001, respectively), and a relationship between dose and response was also identified. Hematologic effects were transient; 91 of the residents who returned for a 9 month follow-up showed marked improvement in or resolution of hematologic abnormalities. The authors speculate the hematologic effects resulted from pyrolytic products of Halon-1211 and Freon-12 (Lo et al, 2006).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) CONTACT DERMATITIS
    1) WITH POISONING/EXPOSURE
    a) Fluorocarbons may produce contact dermatitis (Bircher et al, 1994; Valdivieso et al, 1987; Proctor & Hughes, 1978).
    B) DERMATITIS
    1) WITH POISONING/EXPOSURE
    a) Freon solvents are degreasers. Defatting of the skin and erythema occur after contact.
    b) Liquid Halon 2402 was not a skin irritant when applied to the intact or abraded skin of rabbits (Technical Information, 1987b).
    c) Chemical burns were reported in 16 cases during a 7 year period following mishaps related to Freon-113 (Voge, 1989).
    C) INJECTION
    1) WITH POISONING/EXPOSURE
    a) SUBCUTANEOUS INJECTION
    1) ACCIDENTAL INJECTION: Four adults who received accidental injections of Freon-113(R) in the hand, knee, elbow, and forehead experienced temporary local redness, which progressed over 30 to 40 minutes to more widespread blotchy redness, then subsided. No other manifestations were noted (Personal Communication, 1988).
    2) ACCIDENTAL INJECTION: Goetting et al (1992) reported 4 cases of accidental Freon injection with signs including edema and transient pain. All injuries healed after conservative treatment, with no lasting sequelae (Goetting et al, 1992).
    3) ACCIDENTAL INJECTION: High-pressure injection of a mixture of isopropanol and Freon into a finger resulted in initial pain from the injection site to the axilla, which resolved over several hours with minimal tissue injury (Craig, 1984).
    4) HIGH PRESSURE INJECTION INJURIES: Five patients presented with high-pressure hand injection injuries caused by dry cleaning solvents (eg, isoparaffinic hydrocarbons, methoxypropanol, and dichlorofluoroethane). Although initial symptoms were minimal, significant swelling, discoloration, and pain occurred several hours later. All patients underwent incision, drainage, and debridement, and 2 patients required secondary explorations. One patient developed progressive tip necrosis and 2 episodes of cellulitis over the next 8 weeks. His injected digit was amputated when his necrotic finger demarcated at the proximal interphalangeal joint level. The suggested mechanisms of injury include direct tissue necrosis from the toxic effects of the injected substance, high pressure generated by the injection gun (up to 69,000 kPa), and ischemia resulting from tissue distension. The final outcome of these injuries will be determined by the amount of toxic material injected, the presence of secondary infection, and delay in proper treatment (Gutowski et al, 2003).
    D) FROSTBITE
    1) WITH POISONING/EXPOSURE
    a) Frostbite results from direct Freon exposure and is related to the high volatility of many of these compounds (Goldsmith, 1989).
    b) CASE REPORT: Severe frostbite of the hand and shoulder developed after direct close range exposure to monochlorodifluoromethane for an unknown period of time.
    1) The patient presented 14 hours after exposure with compartment syndrome of the volar forearm and the adductor and interosseous compartments of the hand. Necrosis developed despite fasciotomy, requiring amputation of the fourth and fifth digits and ulnar half of the hand (Wegener et al, 1991).
    c) CASE REPORT: A case of facial and oral exposure led to third degree burns of the lids and face and compromise of the airway (Kurbat & Pollack, 1998).
    d) CASE REPORT: Intentional oral inhalation of airbrush propellant (1,1-difluoroethane) in a 16-year-old boy resulted in loss of consciousness and frozen lips and tongue. First- and second-degree burns of the larynx were noted as well as vocal cord involvement. His trachea, bronchi, and esophagus sustained first-degree burns, and the oral cavity had second- and third-degree burns requiring debridement (Kuspis & Krenzelok, 1999).
    e) CASE REPORT: A 20-year-old man presented to the emergency department with pain, edema, and blistering, numbness, and tingling of the lips, cheeks, tongue, and fingers of the left hand. Initially, the patient indicated that he had possibly been bitten by a spider while camping, and he was subsequently treated with IV epinephrine, corticosteroids, and diphenhydramine for a suspected anaphylactic reaction. Over the next two days, the pain continued with development of large bullae on his face (right cheek, right nostril, lips) and on the fingers of his left hand, with the lesions on his face becoming honey-crusted and ulceration of his upper lip. After further questioning, the patient admitted that he had been inhaling an aerosolized computer cleaner containing a fluorinated hydrocarbon (HFC-134a) one hour prior to presentation until he lost consciousness. A diagnosis of an allergic reaction due to frostbite secondary to contact with HFC-134a was made. Following supportive care and continued observation, the patient gradually recovered without sequelae, although he required extensive outpatient occupational therapy to regain full use of his left hand (Koehler & Henninger, 2014).
    E) ACNE
    1) WITH POISONING/EXPOSURE
    a) Severe acne developed in a 50-year-old man exposed to dihydrotrifluoromethylphenyl benzothiopyranopyrazolone (Scerri et al, 1995).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) RHABDOMYOLYSIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 43-year-old man was reported to be susceptible to malignant hyperthermia by in vitro testing of muscle, developed malaise, stiffness, and weakness in his forearms after taking a job that involved discharging bromochlorodifluoromethane fire extinguishers. Clinical manifestations included CPK levels of 1056 International Units/L (Denborough & Hopkkinson, 1988).
    b) Brady et al (1994) report a case of cardiac arrest from intentional Freon inhalation resulting in rhabdomyolysis with an increase in CPK originating entirely from skeletal muscle (Brady et al, 1994a).
    c) An anesthetic state induced by 1,1-dichloro-1-fluoroethane has been associated with hyperactivity of the skeletal muscles (Johansson, 1998).
    d) Elevated creatine phosphokinase (max range 360-2023) occurred in 2 of 80 workers exposed to Freon-22 after a freezer exploded at a seafood factory; levels returned to normal within 7 days. Approximately 43 kg of Freon-22 escaped into the factory over 10 minutes, and 43 of 80 exposed workers developed symptoms (Kubota & Miyata, 2005).
    B) COMPARTMENT SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Compartment syndrome is a rare complication of direct Freon exposure.
    b) CASE REPORT: Severe frostbite of the hand and shoulder developed after direct close-range exposure to monochlorodifluoromethane for an unknown period of time.
    1) The patient presented 14 hours after exposure with compartment syndrome of the volar forearm and the adductor and interosseous compartments of the hand. Necrosis developed despite fasciotomy, requiring amputation of the fourth and fifth digits and ulnar half of the hand (Wegener et al, 1991).

Immunologic

    3.19.2) CLINICAL EFFECTS
    A) ANAPHYLACTOID REACTION
    1) WITH POISONING/EXPOSURE
    a) A 31-year-old woman with a history of asthma and anaphylactoid reactions to foods developed pruritus, bronchospasm, abdominal cramps, vomiting, flushing, and facial edema, which resolved with epinephrine after using a leather protector containing a fluorocarbon (FX-3532) with ethyl acetate as a carrier in an enclosed space (McHugh, 1995).

Reproductive

    3.20.1) SUMMARY
    A) Dichlorodifluoromethane was not teratogenic in rats and rabbits.
    B) The reproductive effects of 1,1,1,2-tetrafluoroethane were studied in rats. No adverse effects on reproductive performance was noted or on the development, maturation or reproductive performance of up to two successive generations.
    3.20.2) TERATOGENICITY
    A) LACK OF EFFECT
    1) Dichlorodifluoromethane was not teratogenic in rats and rabbits (Schardein, 2000).
    3.20.3) EFFECTS IN PREGNANCY
    A) ANIMAL STUDIES
    1) The reproductive effects of 1,1,1,2-tetrafluoroethane were studied in rats. No adverse effects on reproductive performance was noted or on the development, maturation or reproductive performance of up to two successive generations (Alexander et al, 1996).

Genotoxicity

    A) The hydrochlorofluorocarbons, HCFC-225ca and HCFC-225cb, were not mutagenic in the Ames reverse mutation assay, or clastogenic in the chromosomal aberration assay with Chinese hamster lung cells. Neither induced unscheduled DNA synthesis in liver cells. Both of these agents were clastogenic in the chromosomal aberration assay with human lymphocytes.

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Monitor liver enzymes, serum electrolytes and renal function in symptomatic patients.
    B) Most patients with minor exposure need no specific studies.
    C) Obtain a chest radiograph in any patient with pulmonary symptoms.
    D) Monitor pulse oximetry, institute continuous cardiac monitoring and obtain an ECG.
    E) Expired air levels can be obtained, but these are not available or clinically relevant in the emergency setting.

Radiographic Studies

    A) CHEST RADIOGRAPH
    1) Obtain a chest x-ray in patients with pulmonary symptoms.

Methods

    A) CHROMATOGRAPHY
    1) Identification in blood can be obtained by flame ionization gas chromatography (Garriott & Petty, 1980).
    2) GAS CHROMATOGRAPHY/MASS SPECTROMETRY - was also successfully used to identify 1,1-difluoroethane in tissue samples of a young adult found dead. The cause of death was determined to be inhalation of difluoroethane contained in an aerosol computer cleaner (Xiong et al, 2004).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) Admit any patient with altered mental status, hemodynamic instability, history of an intentional ingestion, suspected or known significant overdose or high pressure digit injury.
    6.3.1.2) HOME CRITERIA/ORAL
    A) Instate home management only if patient is asymptomatic, exposure was minimal and there is no suspicion for self-harm.
    6.3.1.3) CONSULT CRITERIA/ORAL
    A) Involve a toxicologist or poison center immediately if there is concern for intentional or significant overdose. Consult an orthopedic surgeon if there is concern for a high pressure digit injury. Consult ophthalmology if corneal injury is suspected and involve a burn surgeon as needed.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) Observe all patients until completely asymptomatic
    6.3.3) DISPOSITION/INHALATION EXPOSURE
    6.3.3.1) ADMISSION CRITERIA/INHALATION
    A) Admit any patient with altered mental status, hemodynamic instability, history of an intentional ingestion, suspected or known significant overdose or high pressure digit injury.
    6.3.3.2) HOME CRITERIA/INHALATION
    A) Instate home management only if patient is asymptomatic, exposure was minimal and there is no suspicion for self-harm.
    6.3.3.3) CONSULT CRITERIA/INHALATION
    A) Involve a toxicologist or poison center immediately if there is concern for intentional or significant overdose. Consult an orthopedic surgeon if there is concern for a high pressure digit injury. Consult ophthalmology if corneal injury is suspected and involve a burn surgeon as needed.
    6.3.3.5) OBSERVATION CRITERIA/INHALATION
    A) Observe all patients until completely asymptomatic
    6.3.5) DISPOSITION/DERMAL EXPOSURE
    6.3.5.1) ADMISSION CRITERIA/DERMAL
    A) Admit any patient with altered mental status, hemodynamic instability, history of an intentional ingestion, suspected or known significant overdose or high pressure digit injury.
    6.3.5.2) HOME CRITERIA/DERMAL
    A) Instate home management only if patient is asymptomatic, exposure was minimal and there is no suspicion for self-harm.
    6.3.5.3) CONSULT CRITERIA/DERMAL
    A) Involve a toxicologist or poison center immediately if there is concern for intentional or significant overdose. Consult an orthopedic surgeon if there is concern for a high pressure digit injury. Consult ophthalmology if corneal injury is suspected and involve a burn surgeon as needed.
    6.3.5.5) OBSERVATION CRITERIA/DERMAL
    A) Observe all patients until completely asymptomatic

Monitoring

    A) Monitor liver enzymes, serum electrolytes and renal function in symptomatic patients.
    B) Most patients with minor exposure need no specific studies.
    C) Obtain a chest radiograph in any patient with pulmonary symptoms.
    D) Monitor pulse oximetry, institute continuous cardiac monitoring and obtain an ECG.
    E) Expired air levels can be obtained, but these are not available or clinically relevant in the emergency setting.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) SUMMARY
    1) Few oral exposures to liquid fluorinated hydrocarbons have been described including a single ingestion resulting in gastric perforation. Ipecac-induced emesis and activated charcoal are not recommended. These products may cause frostbite injury to the upper airway and gastrointestinal tract. Administer oxygen and manage airway as clinically indicated.
    6.5.2) PREVENTION OF ABSORPTION
    A) EMESIS
    1) Few oral exposures to liquid fluorinated hydrocarbons have been described. A single case of gastric perforation following ingestion of trichlorofluoromethane has been reported.
    2) These substances may cause frostbite to the upper airway and gastrointestinal tract after ingestion. Emesis, activated charcoal, and gastric lavage are not recommended.
    6.5.3) TREATMENT
    A) SUPPORT
    1) MANAGEMENT OF MILD TO MODERATE TOXICITY
    a) Treatment is primarily supportive with removal from source, appropriate decontamination and oxygen administration.
    2) MANAGEMENT OF SEVERE TOXICITY
    a) Remove patient from exposure, decontaminate, and administer oxygen. Aggressive airway management for patients with respiratory or mental status depression should be instated along with supportive measures for hypotension. Administer nebulized bronchodilators (eg, albuterol) for respiratory irritation or bronchospasm. Consider surfactant administration (80ml/m(2) divided into 4 aliquots given every 12 hours through the endotracheal tube using four positions-left decubitus, head-up then down, right decubitus, head-up then down) for patients with a severe pneumonitis requiring intubation. Treat tachydysrhythmias with esmolol 0.025 to 0.1mg/kg/min IV. Cardiovert unstable ventricular dysrhythmias. Consider early ECMO for pediatric patients with severe pneumonitis. Consider N-acetylcysteine for severe liver injury.
    B) MONITORING OF PATIENT
    1) Monitor liver enzymes, serum electrolytes and renal function in symptomatic patients.
    2) Most patients with minor exposure need no specific studies.
    3) Obtain a chest radiograph in any patient with pulmonary symptoms.
    4) Monitor pulse oximetry, institute continuous cardiac monitoring and obtain an ECG.
    5) Expired air levels can be obtained, but these are not available or clinically relevant in the emergency setting.

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) Move patient from the toxic environment to fresh air. Monitor for respiratory distress. If cough or difficulty in breathing develops, evaluate for hypoxia, respiratory tract irritation, bronchitis, or pneumonitis.
    B) OBSERVATION: Carefully observe patients with inhalation exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.
    C) INITIAL TREATMENT: Administer 100% humidified supplemental oxygen, perform endotracheal intubation and provide assisted ventilation as required. Administer inhaled beta-2 adrenergic agonists, if bronchospasm develops. Consider systemic corticosteroids in patients with significant bronchospasm (National Heart,Lung,and Blood Institute, 2007). Exposed skin and eyes should be flushed with copious amounts of water.
    6.7.2) TREATMENT
    A) SUPPORT
    1) MANAGEMENT OF MILD TO MODERATE TOXICITY
    a) Treatment is primarily supportive with removal from source, appropriate decontamination and oxygen administration.
    2) MANAGEMENT OF SEVERE TOXICITY
    a) Remove patient from exposure, decontaminate, and administer oxygen. Aggressive airway management for patients with respiratory or mental status depression should be instated along with supportive measures for hypotension. Administer nebulized bronchodilators (eg, albuterol) for respiratory irritation or bronchospasm. Consider surfactant administration (80ml/m(2) divided into 4 aliquots given every 12 hours through the endotracheal tube using four positions-left decubitus, head-up then down, right decubitus, head-up then down) for patients with a severe pneumonitis requiring intubation. Treat tachydysrhythmias with esmolol 0.025 to 0.1mg/kg/min IV. Cardiovert unstable ventricular dysrhythmias. Consider early ECMO for pediatric patients with severe pneumonitis. Consider N-acetylcysteine for severe liver injury.
    3) Once cardiac dysrhythmias develop, they are difficult to reverse, but a successful cardioversion with complete recovery has been recorded (Brilliant & Grillo, 1993). Ventricular fibrillation that develops following exposure to fluorinated hydrocarbons can be treated by cardioversion (Brilliant & Grillo, 1993). However, it is not always successful (Lown, 1977; Lerman et al, 1991).
    4) Provide a calm quiet atmosphere to prevent adrenaline surge if patient is seen before cardiac dysrhythmias occur. Minimize physical exertion.
    B) MONITORING OF PATIENT
    1) Monitor liver enzymes, serum electrolytes and renal function in symptomatic patients.
    2) Most patients with minor exposure need no specific studies.
    3) Obtain a chest radiograph in any patient with pulmonary symptoms.
    4) Monitor pulse oximetry, institute continuous cardiac monitoring and obtain an ECG.
    5) Expired air levels can be obtained, but these are not available or clinically relevant in the emergency setting.
    C) PULMONARY EDEMA
    1) If phosgene is produced, anticipation of and treatment of pulmonary edema is the key objective.
    2) ONSET: Onset of acute lung injury after toxic exposure may be delayed up to 24 to 72 hours after exposure in some cases.
    3) NON-PHARMACOLOGIC TREATMENT: The treatment of acute lung injury is primarily supportive (Cataletto, 2012). Maintain adequate ventilation and oxygenation with frequent monitoring of arterial blood gases and/or pulse oximetry. If a high FIO2 is required to maintain adequate oxygenation, mechanical ventilation and positive-end-expiratory pressure (PEEP) may be required; ventilation with small tidal volumes (6 mL/kg) is preferred if ARDS develops (Haas, 2011; Stolbach & Hoffman, 2011).
    a) To minimize barotrauma and other complications, use the lowest amount of PEEP possible while maintaining adequate oxygenation. Use of smaller tidal volumes (6 mL/kg) and lower plateau pressures (30 cm water or less) has been associated with decreased mortality and more rapid weaning from mechanical ventilation in patients with ARDS (Brower et al, 2000). More treatment information may be obtained from ARDS Clinical Network website, NIH NHLBI ARDS Clinical Network Mechanical Ventilation Protocol Summary, http://www.ardsnet.org/node/77791 (NHLBI ARDS Network, 2008)
    4) FLUIDS: Crystalloid solutions must be administered judiciously. Pulmonary artery monitoring may help. In general the pulmonary artery wedge pressure should be kept relatively low while still maintaining adequate cardiac output, blood pressure and urine output (Stolbach & Hoffman, 2011).
    5) ANTIBIOTICS: Indicated only when there is evidence of infection (Artigas et al, 1998).
    6) EXPERIMENTAL THERAPY: Partial liquid ventilation has shown promise in preliminary studies (Kollef & Schuster, 1995).
    7) CALFACTANT: In a multicenter, randomized, blinded trial, endotracheal instillation of 2 doses of 80 mL/m(2) calfactant (35 mg/mL of phospholipid suspension in saline) in infants, children, and adolescents with acute lung injury resulted in acute improvement in oxygenation and lower mortality; however, no significant decrease in the course of respiratory failure measured by duration of ventilator therapy, intensive care unit, or hospital stay was noted. Adverse effects (transient hypoxia and hypotension) were more frequent in calfactant patients, but these effects were mild and did not require withdrawal from the study (Wilson et al, 2005).
    8) However, in a multicenter, randomized, controlled, and masked trial, endotracheal instillation of up to 3 doses of calfactant (30 mg) in adults only with acute lung injury/ARDS due to direct lung injury was not associated with improved oxygenation and longer term benefits compared to the placebo group. It was also associated with significant increases in hypoxia and hypotension (Willson et al, 2015).
    D) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) It has been suggested that splash contact with liquid freons be treated with olive oil (Cordes, 1950). However, this is unlikely to be effective since the freon will rapidly vaporize a few seconds after exposure (Grant & Schuman, 1993).
    B) EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).
    C) Damage to the eyelids should be evaluated and followed up by an ophthalmologist.

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DECONTAMINATION: Remove contaminated clothing and wash exposed area thoroughly with soap and water for 10 to 15 minutes. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    6.9.2) TREATMENT
    A) FROSTBITE
    1) PREHOSPITAL
    a) Rewarming of a localized area should only be considered if the risk of refreezing is unlikely. Avoid rubbing the frozen area which may cause further damage to the area (Grieve et al, 2011; Hallam et al, 2010).
    2) REWARMING
    a) Do not institute rewarming unless complete rewarming can be assured; refreezing thawed tissue increases tissue damage. Place affected area in a water bath with a temperature of 40 to 42 degrees Celsius for 15 to 30 minutes until thawing is complete. The bath should be large enough to permit complete immersion of the injured part, avoiding contact with the sides of the bath. A whirlpool bath would be ideal. Some authors suggest a mild antibacterial (ie, chlorhexidine, hexachlorophene or povidone-iodine) be added to the bath water. Tissues should be thoroughly rewarmed and pliable; the skin will appear a red-purple color (Grieve et al, 2011; Hallam et al, 2010; Murphy et al, 2000).
    b) Correct systemic hypothermia which can cause cold diuresis due to suppression of antidiuretic hormone; consider IV fluids (Grieve et al, 2011).
    c) Rewarming may be associated with increasing acute pain, requiring narcotic analgesics.
    d) For severe frostbite, clinical trials have shown that pentoxifylline, a phosphodiesterase inhibitor, can enhance tissue viability by increasing blood flow and reducing platelet activity (Hallam et al, 2010).
    3) WOUND CARE
    a) Digits should be separated by sterile absorbent cotton; no constrictive dressings should be used. Protective dressings should be changed twice per day.
    b) Perform twice daily hydrotherapy for 30 to 45 minutes in warm water at 40 degrees Celsius. This helps debride devitalized tissue and maintain range of motion. Keep the area warm and dry between treatments (Hallam et al, 2010; Murphy et al, 2000).
    c) The injured extremities should be elevated and should not be allowed to bear weight.
    d) In patients at risk for infection of necrotic tissue, prophylactic antibiotics and tetanus toxoid have been recommended by some authors (Hallam et al, 2010; Murphy et al, 2000).
    e) Non-tense clear blisters should be left intact due to the risk of infection; tense or hemorrhagic blisters may be carefully aspirated in a setting where aseptic technique is provided (Hallam et al, 2010).
    f) Further surgical debridement should be delayed until mummification demarcation has occurred (60 to 90 days). Spontaneous amputation may occur.
    g) Analgesics may be required during the rewarming phase; however, patients with severe pain should be evaluated for vasospasm.
    h) IMAGING: Arteriography and noninvasive vascular techniques (e.g., plain radiography, laser Doppler studies, digital plethysmography, infrared thermography, isotope scanning), have been useful in evaluating the extent of vasospasm after thawing and assessing whether debridement is needed (Hallam et al, 2010). In cases of severe frostbite, Technetium 99 (triple phase scanning) and MRI angiography have been shown to be the most useful to assess injury and determine the extent or need for surgical debridement (Hallam et al, 2010).
    i) TOPICAL THERAPY: Topical aloe vera may decrease tissue destruction and should be applied every 6 hours (Murphy et al, 2000).
    j) IBUPROFEN THERAPY: Ibuprofen, a thromboxane inhibitor, may help limit inflammatory damage and reduce tissue loss (Grieve et al, 2011; Murphy et al, 2000). DOSE: 400 mg orally every 12 hours is recommended (Hallam et al, 2010).
    k) THROMBOLYTIC THERAPY: Thrombolysis (intra-arterial or intravenous thrombolytic agents) may be beneficial in those patients at risk to lose a digit or a limb, if done within the first 24 hours of exposure. The use of tissue plasminogen activator (t-PA) to clear microvascular thromboses can restore arterial blood flow, but should be accompanied by close monitoring including angiography or technetium scanning to evaluate the injury and to evaluate the effects of t-PA administration. Potential risk of the procedure includes significant tissue edema that can lead to a rise in interstitial pressures resulting in compartment syndrome (Grieve et al, 2011).
    l) CONTROVERSIAL: Adjunct pharmacological agents (ie, heparin, vasodilators, prostacyclins, prostaglandin synthetase inhibitors, dextran) are controversial and not routinely recommended. The role of hyperbaric oxygen therapy, sympathectomy remains unclear (Grieve et al, 2011).
    m) CHRONIC PAIN: Vasomotor dysfunction can produce chronic pain. Amitriptyline has been used in some patients; some patients may need a referral for pain management. Inability to tolerate the cold (in the affected area) has been observed following a single episode of frostbite (Hallam et al, 2010).
    n) MORBIDITIES: Frostbite can produce localized osteoporosis and possible bone loss following a severe case. These events may take a year or more to develop. Children may be at greater risk to develop more severe events (ie, early arthritis) (Hallam et al, 2010).
    B) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Enhanced Elimination

    A) ENHANCED ELIMINATION
    1) There is no evidence to support hemodialysis, hemoperfusion, diuresis or multi-dose activated charcoal.

Case Reports

    A) ADULT
    1) Two soldiers were exposed by inhalation to bromochlorodifluoromethane (BCF) in a battle tank after extinguishing a fire with a BCF extinguisher. Both experienced dizziness and dyspnea at first; 1 soldier was able to get out of the tank and symptoms resolved within 60 seconds; the other was unable to get out and died 2 hours after the exposure. Brain edema, severe bilateral pulmonary edema, and alveoli filled with a foamy bloody fluid were among the postmortem findings. The concentration of BCF in the compartment containing the fatality victim was estimated at 11.9% (Lerman et al, 1991).
    B) PEDIATRIC
    1) An 8-year-old was found comatose in a swimming pool after she attempted to further inflate by mouth a pool float partially filled with Freon. Gross hemoptysis (100 to 200 mL) occurred during resuscitation. She developed ARDS and required intubation and prolonged ventilatory support, but recovered (Thompson & Snodgrass, 1991).
    2) A 6-year-old who inhaled Freon from a party balloon lost consciousness and developed asystole. Restoration of a normal sinus rhythm was achieved. A CT scan and EEG done at 6 hours postexposure revealed evidence of brain death, and ventilatory support was subsequently discontinued on day 3 (Thompson & Snodgrass, 1991).

Summary

    A) Freons are very toxic when inhaled in high concentrations and/or for extended periods. At lower concentrations or brief exposure, freons may cause transient eye, nose, and throat irritation.
    B) DICHLORODIFLUOROMETHANE: OSHA PEL and NIOSH REL: TWA 1000 parts per million (ppm); 15,000 ppm is considered immediately dangerous to life and health. TRIFLUOROBROMOMETHANE: OSHA PEL and NIOSH REL: TWA 1000 ppm; 40,000 ppm is considered immediately dangerous to life and health. DICHLOROMONOFLUOROMETHANE: OSHA PEL: TWA 1000 ppm, NIOSH REL: TWA 10 ppm; 5,000 ppm is considered immediately dangerous to life and health.

Minimum Lethal Exposure

    A) A soldier, in a battle tank, died following an inhalation exposure to an estimated concentration of 11.9% chlorodifluoromethane (Lerman et al, 1991).
    B) CASE REPORT: Three men (aged 22 to 41 years) died after inhaling 1,1-difluoroethane (HFC-152a), a common formulation for electronic spray cleaners. No report of intentional suicide was found in all 3 cases. Two spent canisters (approximate volume 500 mL) were found in 1 case, and 1 canister of the same size along with barrier asphyxiants with attached tubes (eg, plastic bag and gas mask) were found with the other 2 cases. All patients were discovered in the early to late stages of rigor mortis. Similar findings on autopsy for each case included cyanosis of the lips and fingernails, alveolar edema, and pulmonary congestion. The man in the first case also had frostbite on the dorsa of the hand, most likely due to extensive exposure to the cold exterior of the canisters while inhaling the fumes(Sakai et al, 2011).
    C) CASE SERIES: Twelve factory workers presented to a local hospital with a dry cough after their shift. Exposure to an open-air discharge of fluorocarbons and pyrolysis products occurred from a neighboring factory approximately 35 meters away. Investigation of the workshop of the exposed factory workers, 22 hours after the discharge, detected perfluoroisobutylene, hydrogen fluoride, hexafluoropropylene, tetrafluoroethylene, and chlorotrifluoroethylene at levels of 0.06, 0.08, 0.7, 1.8, and 0.5 mg/m(3), respectively. One of the 12 patients died of respiratory failure within hours of presentation. The other 11 patients were transferred to another hospital due to increasing dyspnea. Urinalysis revealed a urinary fluoride concentration of greater than 1.72 mcg/mL in all patients, which was at the upper limit of the reference value. Initial chest radiographs in 5 patients demonstrated pulmonary edema, and those 5 patients also met the criteria for acute respiratory distress syndrome (ARDS). Chest radiographs in the other 6 patients showed increased lung markings and mild interstitial infiltrates. Treatment for the ARDS patients included non-invasive positive pressure ventilation (NIPPV) with IV methylprednisolone and inhaled budesonide. Two of the ARDS patients developed subcutaneous emphysema and pneumomediastinum which resolved with NIPPV treatment. CT scan of 4 ARDS patients demonstrated bilateral ground-glass opacities and interstitial pneumonia which gradually improved over a 3-month period. One patient died on day 11 due to ventilator-associated pneumonia (Tan et al, 2016).

Maximum Tolerated Exposure

    A) TOXIC DOSE
    1) Dichlorodifluoromethane: OSHA PEL and NIOSH REL: TWA 1000 parts per million (ppm); 15,000 ppm is considered immediately dangerous to life and health (National Institute for Occupational Safety and Health (NIOSH) Education and Information Division, 2009).
    2) Trifluorobromomethane: OSHA PEL and NIOSH REL: TWA 1000 ppm; 40,000 ppm is considered immediately dangerous to life and health (Centers for Disease Control and Prevention, 2009)
    3) Dichloromonofluoromethane: OSHA PEL: TWA 1000 ppm, NIOSH REL: TWA 10 ppm; 5000 ppm is considered immediately dangerous to life and health (Centers for Disease Control and Prevention, 2009)
    4) A soldier, in a battle tank, died following an inhalation exposure to an estimated concentration of 11.9 percent bromochlorodifluoromethane (Lerman et al, 1991).
    5) CASE SERIES: Twelve factory workers presented to a local hospital with a dry cough after their shift. Exposure to an open-air discharge of fluorocarbons and pyrolysis products occurred from a neighboring factory approximately 35 meters away. Investigation of the workshop of the exposed factory workers, 22 hours after the discharge, detected perfluoroisobutylene, hydrogen fluoride, hexafluoropropylene, tetrafluoroethylene, and chlorotrifluoroethylene at levels of 0.06, 0.08, 0.7, 1.8, and 0.5 mg/m(3), respectively. One of the 12 patients died of respiratory failure within hours of presentation. The other 11 patients were transferred to another hospital due to increasing dyspnea. Urinalysis revealed a urinary fluoride concentration of greater than 1.72 mcg/mL in all patients, which was at the upper limit of the reference value. Initial chest radiographs in 5 patients demonstrated pulmonary edema, and those 5 patients also met the criteria for acute respiratory distress syndrome (ARDS). Chest radiographs in the other 6 patients showed increased lung markings and mild interstitial infiltrates. Treatment for the ARDS patients included non-invasive positive pressure ventilation (NIPPV) with IV methylprednisolone and inhaled budesonide. Two of the ARDS patients developed subcutaneous emphysema and pneumomediastinum which resolved with NIPPV treatment. CT scan of 4 ARDS patients demonstrated bilateral ground-glass opacities and interstitial pneumonia which gradually improved over a 3-month period. One patient died on day 11 due to ventilator-associated pneumonia (Tan et al, 2016).
    B) SPECIFIC SUBSTANCE
    1) Freons are very toxic when sniffed in high concentrations and/or for extended periods. There is significant variation in tolerance between patients.
    2) BROMOCHLORODIFLUOROMETHANE
    a) Exposure to BCF concentrations of 4 to 5 percent may result in dizziness and tingling of the fingers after 1 minute (Lerman et al, 1991).
    b) Exposure to BCF concentrations of 10 percent or greater may result in light-headedness, dizziness, altered mental status, and a slowed reaction time, followed by arrhythmias, and death (Lerman et al, 1991).
    3) HALON 2402
    a) Exposure to 500 ppm for 4 hours produced no symptoms in rats (Technical Information, 1987a).
    b) Exposure to 1000 ppm for 1 hour produced ataxia and dizziness in rats and is considered to be unsafe for human exposure (Technical Information, 1987a).
    c) Exposure to 2000 ppm for 2 minutes produced ataxia and dizziness in rats (Technical Information, 1987a).
    d) Oral ingestion of 5 grams/kg in rats did not result in any detectable toxicity (Technical Information, 1987b).
    C) ROUTE OF EXPOSURE
    1) DYSRHYTHMIA
    a) In one human subject wearing an ambulatory EKG, exposure to 10,000 cm(3)/m(3) of FC 12 for 2.5 hours produced no arrhythmia (Azar et al, 1972).
    b) No clear connection with exposure and cardiac arrhythmias could be found in 6 refrigerator repairmen wearing ambulatory electrocardiograms for 24 hours on the day of exposure and on a control day. Peak concentration and average level of exposure in the breathing zone were 3200 cm(3)/m(3) and 170 cm(3)/m(3), respectively (Antti-Poika et al, 1990).
    c) In animal experiments, much higher concentrations (100,000 to 200,000 cm(3)/m(3)) of fluorinated hydrocarbons were required for production of arrhythmias (Aviado & Micozzi, 1981).

Serum Plasma Blood Concentrations

    7.5.2) TOXIC CONCENTRATIONS
    A) TOXIC CONCENTRATION LEVELS
    1) SPECIFIC SUBSTANCE
    a) The peak blood level occurs immediately after inhalation. Within 15 minutes the level is down almost completely. Significance of blood levels in relationship to catecholamine-induced dysrhythmias is unknown.
    b) FREON 11
    1) Post mortem tissue levels in a case of fatal freon 11 poisoning were as follows (Groppi et al, 1994) -
    TissueFreon 11 (mg/kg)
    Blood62.8
    Brain108.9
    Lung149.1
    Heart406.6
    Liver74.1
    Kidney50.2
    Spleen20.6

    c) CHLORODIFLUOROMETHANE & CHLOROPENTAFLUOROETHANE
    1) Post mortem tissue levels in a case of fatal chlorodifluoromethane and chloropentafluoroethane abuse were as follows (Fitzgerald et al, 1993) -
     ChlorodifluoromethaneChloropentafluoroethane
    Blood71 mg/L0.30 mg/L
    Brain2.8 mg/kg0.80 mg/kg
    Liver4.4 mg/kg0.80 mg/kg
    Lung1.6 mg/kg0.11 mg/kg

    d) DIFLUOROETHANE
    1) Post mortem tissue levels were obtained in a young adult following intentional difluoroethane inhalation (exposure was secondary to abuse of an aerosol computer cleaner containing 1,1-difluoroethane): (Xiong et al, 2004)
    TISSUEDIFLUOROETHANE CONCENTRATION
    Femoral Blood*83.5 mg/L
    Brain43.8 mg/kg
    Lung91.1 mg/kg
    Liver92.7 mg/kg
    Kidney24.3 mg/kg
    Muscle80.5 mg/kg
    Adipose29.8 mg/kg
    Pulmonary Blood*141.1 mg/L
    Aortic Blood*122.7 mg/L

    2) *Samples were not sealed in headspace vials at autopsy.

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) LD50- (INHALATION)RAT:
    1) 50,000 ppm for 4 hours (Technical Information, 1987a)

Toxicologic Mechanism

    A) DERMAL EFFECTS - Fluorinated hydrocarbons have very low boiling points and may cause frostbite or freezing if in contact with skin for more than 3 to 5 seconds (ie if sprayed directly from the aerosol at close range).
    B) THERMAL DECOMPOSITION - If fluorinated hydrocarbon vapors are thermally cracked (decomposed) in open flames or arcs associated with furnaces, boilers, or welding operations, toxic gasses are produced (fluorine, hydrogen fluoride, chlorine, phosgene) (Finkel, 1983).
    C) DYSRHYTHMIAS - Autopsy findings in victims of sudden death associated with fluorinated hydrocarbon sniffing have been nonspecific (pulmonary edema, visceral congestion) suggesting dysrhythmia as the cause of death (Garriot & Petty, 1980; (Smeeton, 1985).
    1) SUDDEN DEATH - is often preceded by sudden exertion. It is postulated that fluorinated hydrocarbons cause sudden death by sensitizing the heart to the arrhythmogenic action of endogenous catecholamines (Smeeton, 1985).
    2) ANIMAL STUDIES - In dogs, inhalation of fluorinated hydrocarbon vapors causes bradycardia followed by junctional or ventricular escape with deterioration to asystole or ventricular fibrillation in some animals (Flowers & Horan, 1972a) Flowers & Horan 1972b). This occurs despite maintenance of normal oxygen and carbon dioxide tension, pH, base excess, and serum carbon dioxide.
    a) Epinephrine doses that produced minimal ECG alterations when administered alone, produced ventricular tachycardia and fibrillation when administered to dogs pretreated with bromochlorodifluoromethane (Beck et al, 1973).
    3) IN VITRO - In isolated rat and human papillary muscles, dichlorodifluoromethane depresses contractility (Harris, 1973).

Physical Characteristics

    A) Freon has an odor said to resemble that of fresh-cut grass (Windholz et al, 1983; Reynolds, 1982).
    B) Halon 1211 is an odorless, colorless gas, and in the gaseous state, it is five times heavier than air (Lerman et al, 1991).

Molecular Weight

    A) Varies

General Bibliography

    1) Alexander DJ, Libretto SE, & Adams MJ: HFA-134a (1,1,1,2-tetrafluoroethane): effects of inhalation exposure upon reproductive performance, development and maturation of rats. Hum Exp Toxicol 1996; 15:508-517.
    2) Anon: Trichlorofluoromethane. Hygienic Guide Series. Am Ind Hyg Assoc J 1968; 29:517-520.
    3) Antti-Poika M, Heikkila J, & Sarrinen L: Cardiac arrhythmias during occupational exposure to fluorinated hydrocarbons. Br J Ind Med 1990; 47:138-140.
    4) Artigas A, Bernard GR, Carlet J, et al: The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling.. Am J Respir Crit Care Med 1998; 157:1332-1347.
    5) Astier A & Paraire F: Fatal intoxication with 1,1-dichloro-1-fluoroethane (letter). New Engl J Med 1997; 337:940.
    6) Aviado DM & Micozzi MS: Fluorine-containing organic compounds, in Clayton GD & Clayton FE (eds): Patty's Industrial Hygiene and Toxicology, 3rd ed, John Wiley, New York, NY, 1981, pp 3071-3115.
    7) Azar A, Reinhardt CF, & Maxfield ME: Experimental human exposures to fluorocarbon 12. Am Ind Hyg Assoc J 1972; 33:207-216.
    8) Beck PS, Clark DG, & Tinston DJ: The pharmacologic actions of bromochlorodifluoromethane (BCF). Toxicol Appl Pharmacol 1973; 24:20-29.
    9) Bircher AJ, Hampl K, & Hirsbrunner P: Allergic contact dermatitis from ethyl chloride and sensitization to dichlorodifluoromethane (CFC 12). Contact Dermatitis 1994; 31:41-44.
    10) Bracco D & Favre JB: Pulmonary injury after ski wax inhalation exposure. Ann Emerg Med 1998; 32:616-619.
    11) Brady WJ Jr, Stremski E, Eljaiek L, et al: Freon inhalational abuse presenting with ventricular fibrillation.. Am J Emerg Med 1994a; 12:533-536.
    12) Brady WJ, Stremski E, & Eljaiek L: Freon inhalational abuse presenting with ventricular fibrillation. Am J Emerg Med 1994; 12:533-536.
    13) Brilliant LC & Grillo A: Successful resuscitation from cardiopulmonary arrest following deliberate inhalation of Freon refrigerant gas. Del Med J 1993; 65(6):375-378.
    14) Brock WJ, Shin-Ya S, & Rusch GM: Inhalation toxicity and genotoxicity of hydrochlorofluorocarbon (HCFC)-225ca and HCFC-225cb. J Appl Toxicol 1999; 19:101-112.
    15) Brock WJ, Trochimowicz HJ, & Millischer RJ: Acute and subchronic toxicity of 1,1-dichloro-1-fluoroethane (HCFC-141b). Food Chem Toxicol 1995; 33:483-490.
    16) Brower RG, Matthay AM, & Morris A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342:1301-1308.
    17) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    18) Burkhart KK, Britt A, & Petrini G: Pulmonary toxicity following exposure to an aerosolized leather protector. J Toxicol Clin Toxicol 1996; 34:21-24.
    19) CDC: Polymer-fume fever associated with cigarette smoking and the use of tetrafluoroethylene - Mississippi. MMRW Aug. CDC: MMWR 1987; 36(31):515-522.
    20) Call DW: A study of Halon 1301 (CBrF3) toxicity under simulated flight conditions. Aerosp Med 1973; 44:202-204.
    21) Caplan JP, Pope AE, Boric CA, et al: Air conditioner refrigerant inhalation: a habit with chilling consequences. Psychosomatics 2012; 53(3):273-276.
    22) Cataletto M: Respiratory Distress Syndrome, Acute(ARDS). In: Domino FJ, ed. The 5-Minute Clinical Consult 2012, 20th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2012.
    23) Centers for Disease Control and Prevention: NIOSH Pocket Guide to Chemical Hazards: Dichloromonofluoromethane. Centers for Disease Control and Prevention. Atlanta, GA. 2009a. Available from URL: http://www.cdc.gov/niosh/npg/npgd0197.html. As accessed 2010-06-07.
    24) Centers for Disease Control and Prevention: NIOSH Pocket Guide to Chemical Hazards: Trifluorobromomethane. Centers for Disease Control and Prevention. Atlanta, GA. 2009. Available from URL: http://www.cdc.gov/niosh/npg/npgd0634.html. As accessed 2010-06-07.
    25) Clark MA, Jones JW, & Robinson JJ: Multiple deaths resulting from shipboard exposure to trichlorotrifluoroethane. J Forensic Sci 1985; 30:1256-1259.
    26) Cordes FC: Emergency treatment of chemical burns of the eye. Postgrad Med 1950; 7:45.
    27) Craig EV: A new high-pressure injection injury of the hand. J Hand Surg 1984; 9A:240-242.
    28) Denborough MA & Hopkkinson KC: Firefighting and malignant hyperthermia. Br Med J 1988; 296:1442-1443.
    29) Edling C, Ohlson CG, & Ljungkvist G: Cardiac arrhythmia in refrigerator repairmen exposed to fluorocarbons. Br J Ind Med 1990; 47:207-212.
    30) Egeland GM, Bloom TF, & Schnorr TM: Fluorocarbon 113 exposure and cardiac dysrhythmias among aerospace workers. Am J Ind Med 1992; 22:851-857.
    31) Field GB: Occupational asthma due to heated freon (letter). Thorax 1985; 40:320.
    32) Finkel AJ: Hamilton and Hardy's Industrial Toxicology, 4th ed, John Wright, PSG Inc, Boston, MA, 1983.
    33) Fitzgerald RL, Fishel CE, & Bush LLE: Fatality due to recreational use of chlorodifluoromethane and chloropentafluoroethane. J Forensic Sci 1993; 38:476-482.
    34) Flowers NC & Horan LG: The electrical sequelae of aerosol inhalation. Am Heart J 1972a; 83:644-657.
    35) Garriott J & Petty CS: Death from inhalant abuse: toxicologic and pathologic evaluation of 34 cases. Clin Toxicol 1980; 16:305-315.
    36) Gerhardt RT: Acute Halon (bromochlorodifluoromethane) toxicity by accidental and recreational inhalation. Am J Emerg Med 1996; 14(7):675-677.
    37) Goetting AT, Carson J, & Burton BT: Freon injection injury to the hand: a report of four cases. J Occup Med 1992; 34:775-778.
    38) Goldberg ME, Larijani GE, & Eger EI II: Peripheral neuropathy in healthy men volunteers anesthetized with 1.25 MAC sevoflurane for 8 hours. Pharmacotherapy 1999; 19:1173-1176.
    39) Goldsmith RJ: Death by freon (letter). J Clin Psychiatry 1989; 50:36-37.
    40) Gotelli MJ, Monserrat AJ, LoBalbo A, et al: Freon: accidental ingestion and gastric perforation. Clin Toxicol (Phila) 2008; 46(4):325-328.
    41) Grant WM & Schuman JS: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993.
    42) Grieve AW, Davis P, Dhillon S, et al: A clinical review of the management of frostbite. J R Army Med Corps 2011; 157(1):73-78.
    43) Groppi A, Polettini A, & Lunetta P: A fatal case of trichlorofluoromethane (freon 11) poisoning. Tissue distribution study by gas chromatography-mass spectrometry. J Forensic Sci 1994; 39:871-876.
    44) Gutowski KA, Chu J, Choi M, et al: High-pressure hand injection injuries caused by dry cleaning solvents: case reports, review of the literature, and treatment guidelines. Plast Reconstr Surg 2003; 111(1):174-177.
    45) Haas CF: Mechanical ventilation with lung protective strategies: what works?. Crit Care Clin 2011; 27(3):469-486.
    46) Haj M, Burstein Z, & Horn E: Perforation of the stomach due to trichlorofluoromethane (Freon 11) ingestion. Isr J Med Sci 1980; 16:392-394.
    47) Hallam MJ, Cubison T, Dheansa B, et al: Managing frostbite. BMJ 2010; 341:c5864-.
    48) Harris W: Toxic effects of aerosol propellants on the heart. Arch Intern Med 1973; 131:162-166.
    49) Hathaway GJ, Proctor NH, & Hughes JP: Chemical Hazards of the Workplace, 4th ed, Van Nostrand Reinhold Company, New York, NY, 1996.
    50) Hoet P, Graf MLM, & Bourdi M: Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone -sparing substitutes of chlorofluorocarbons. Lancet 1997; 350:556-559.
    51) Holness DL & House RA: Health effects of Halon 1301 exposure. J Occup Med 1992; 34:722-725.
    52) Johansson JS: Fatal intoxication with 1,1-dichloro-1-fluorethane (letter). New Engl J Med 1998; 338:201-202.
    53) Kamm RC: Fatal arrhythmia following deodorant inhalation. Forensic Sci 1975; 5:91-93.
    54) Kaufman JD, Morgan MS, & Marks ML: A study of the cardiac effects of bromochlorodifluoromethane (Halon 1211) exposure during exercise. Am J Ind Med 1992; 21:223-233.
    55) Kaufman JD, Silverstein MA, & Moure-Eraso R: Atrial fibrillation and sudden death related to occupational solvent exposure. Am J Ind Med 1994; 25:731-735.
    56) Kelly KJ & Ruffing R: Acute eosinophilic pneumonia following intentional inhalation of Scotchguard. Ann Allergy 1993; 71:358-361.
    57) Koehler MM & Henninger CA: Orofacial and digital frostbite caused by inhalant abuse. Cutis 2014; 93(5):256-260.
    58) Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37.
    59) Kubota T & Miyata A: Acute inhalational exposure to chlorodifluoromethane (Freon-22): a report of 43 cases. Clin Toxicol 2005; 43:305-308.
    60) Kurbat RS & Pollack CV Jr: Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med 1998; 16(2):167-169.
    61) Kuspis DA & Krenzelok EP: Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon. Clin Toxicol 1999; 37:873-875.
    62) Lam CW, Weir FW, & Williams-Cavender K: Toxicokinetics of inhaled bromotrifluoromethane (Halon 1301) in human subjects. Fundam Appl Toxicol 1993; 20:231-239.
    63) Lerman Y, Winkler E, & Tirosh MS: Fatal accidental inhalation of bromochlorodifluoromethane (Halon 1211). Hum Exp Toxicol 1991; 10:125-128.
    64) Lo SH, Chan CC, Chen WC, et al: Grand rounds: outbreak of hematologic abnormalities in a community of people exposed to leakage of fire extinguisher gas. Environ Health Perspect 2006; 114(11):1713-1717.
    65) Lown B: Electrical reversion of cardiac arrhythmias, in Thorn et al (eds): Harrison's Principal of Internal Medicine, 8th ed, McGraw-Hill, New York, NY, 1977, pp 1216-1219.
    66) Malo JL, Gagnon G, & Cartier A: Occupational asthma due to heated freon. Thorax 1984; 39:628-629.
    67) Matrat M, Laurence MF, Iwatsubo Y, et al: Reactive airways dysfunction syndrome caused by bromochlorodifluoromethane from fire extinguishers. Occup Environ Med 2004; 61:712-714.
    68) May DC & Blotzer MJ: A report of occupational deaths attributed to fluorocarbon-113. Arch Environ Health 1984; 39:352-354.
    69) McGee MB, Meyer RF, & Jejurikar SG: A death resulting from trichlorotrifluorethane poisoning. J Forensic Sci 1990; 35:1453-1460.
    70) McHugh DF: Anaphylaxis and leather protectors (letter). Ann Emerg Med 1995; 26:6.
    71) Mergner GW, Blake DA, & Helrich M: Biotransformation and elimination of 14C-trichlorofluoromethane (FC-11) and dichlorodifluoromethane (FC-12) in man. Anesthesiology 1975; 42:345-351.
    72) Miller HA & Perdriel G: Preliminary note on utilisation of refrigerant gas in ocular surgery. Bull Soc Ophthalmol France 1964; 64:358-364.
    73) Morita M, Miki A, & Kazama H: Case report of deaths caused by freon gas. Forensic Sci 1977; 10:253-260.
    74) Mullin LS: Cardiac arrhythmias and blood levels associated with inhalation of Halon 1301. Am Ind Hyg Assoc J 1979; 40:653-658.
    75) Murphy JV, Banwell PE, & Roberts AHN: Frostbite: pathogenesis and treatment. J Trauma 2000; 48:171-178.
    76) NHLBI ARDS Network: Mechanical ventilation protocol summary. Massachusetts General Hospital. Boston, MA. 2008. Available from URL: http://www.ardsnet.org/system/files/6mlcardsmall_2008update_final_JULY2008.pdf. As accessed 2013-08-07.
    77) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
    78) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    79) National Institute for Occupational Safety and Health (NIOSH) Education and Information Division: NIOSH Pocket Guide to Chemical Hazards: Dichlorodifluoromethane. Centers for Disease Control and Prevention. Atlanta, GA. 2009. Available from URL: http://www.cdc.gov/niosh/npg/npgd0192.html. As accessed 2010-06-16.
    80) Ossiander EM: Volatile substance misuse deaths in Washington State, 2003-2012. Am J Drug Alcohol Abuse 2015; 41(1):30-34.
    81) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
    82) Personal Communication: Personal Communication: William L Sprout, MD. Dupont, Newark, DE, 1988.
    83) Phatak DR & Walterscheid J: Huffing air conditioner fluid: a cool way to die?. Am J Forensic Med Pathol 2012; 33(1):64-67.
    84) Proctor N & Hughes J: Chemical Hazards of the Workplace, Lippincott Co, Philadelphia, PA, 1978.
    85) Rasmussen K, Jeppesen HJ, & Arlien-Soborg P: Psychoorganic syndrome from exposure to Fluorcarbon 113 - an occupational disease?. Eur Neurol 1988; 28:205-207.
    86) Reynolds JE: Martindale: The Extra Pharmacopoeia, 28th ed, The Pharmaceutical Press, London, England, 1982.
    87) Sakai K, Maruyama-Maebashi K, Takatsu A, et al: Sudden death involving inhalation of 1,1-difluoroethane (HFC-152a) with spray cleaner: three case reports. Forensic Sci Int 2011; 206(1-3):e58-e61.
    88) Scerri L, Zaki I, & Millard LG: Severe halogen acne due to a trifluoromethylpyrazole derivative and its resistance to isotretinoin. Br J Dermatol 1995; 132:144-148.
    89) Schardein JL: Chemically Induced Birth Defects, 3rd ed, Marcel Dekker, Inc, New York, NY, 2000.
    90) Smeeton WMI: Sudden death resulting from inhalation of fire extinguishers containing bromochlorodifluoromethane. Med Sci Law 1985; 25:258-262.
    91) Steadman C, Dorrington LC, & Kay P: Abuse of a fire-extinguishing agent and sudden death in adolescents. Med J Aust 1984; 141:115-117.
    92) Stolbach A & Hoffman RS: Respiratory Principles. In: Nelson LS, Hoffman RS, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies, 9th ed. McGraw Hill Medical, New York, NY, 2011.
    93) Tan D, Wang C, Ling J, et al: Acute respiratory distress syndrome after accidental inhalation of fluorocarbon monomers and pyrolysis products. Occup Environ Med 2016; 73(4):287-288.
    94) Technical Information: Halon 2402 Material Safety Data Sheet, Great Lakes Chemical Corporation, West Lafayette, IN, 1987a.
    95) Technical Information: In vitro and in vivo evaluation and analysis of liquid Halon 2402, JWB Associates, Elmhurst, IL, 1987b.
    96) Thompson JD & Snodgrass WR: Inflatable toys - an unusual source of freon toxicity (abstract). Vet Hum Toxicol 1991; 33:363.
    97) Valdivieso R, Pola J, & Zapata C: Contact allergic dermatitis caused by Freon 1 in deodorants. Contact Derm 1987; 17:243-245.
    98) Voge VM: Freon: an unsuspected problem. Aviat Space Environ Med 1989; 60:B27-B28.
    99) Wegener EE, Barraza KR, & Das SK: Severe frostbite caused by freon gas. South Med J 1991; 84:1143-1146.
    100) Willson DF, Truwit JD, Conaway MR, et al: The adult calfactant in acute respiratory distress syndrome (CARDS) trial. Chest 2015; 148(2):356-364.
    101) Wilson DF, Thomas NJ, Markovitz BP, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005; 293:470-476.
    102) Windholz M, Budavari S, & Blumetti RF: The Merck Index, 10th ed, Merck & Co, Inc, Rahway, NJ, 1983.
    103) Winograd HL: Acute croup in an older child. An unusual toxic origin. Clin Pediatr 1977; 16:884-887.
    104) Winston A, Kanzy A, & Bachuwa G: Air Duster abuse causing rapid airway compromise. BMJ Case Rep 2015; 2015:Epub.
    105) Wright GM & Lee A: Alveolitis after use of a leather impregnation spray. Br Med J 1986; 292:727-728.
    106) Xiong Z, Avella J, & Wetli CV: Sudden death caused by 1,1-difluoroethane. J Forensci Sci 2004; 49(3):627-629.
    107) Zierold D & Chauviere M: Hydrogen fluoride inhalation injury because of a fire suppression system. Mil Med 2012; 177(1):108-112.
    108) de la Hoz RE: Reactive airways dysfunction syndrome following exposure to a fluorocarbon. Eur Respir J 1999; 13(5):1192-1194.